Chronic Kidney Disease (CKD) Market Report

Global and Region Chronic Kidney Disease (CKD) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：145
  • REPORT CODE：GMM977563
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chronic Kidney Disease (CKD) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Kidney Disease (CKD)market, defines the market attractiveness level of Chronic Kidney Disease (CKD) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chronic Kidney Disease (CKD) industry, describes the types of Chronic Kidney Disease (CKD) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Kidney Disease (CKD) market and the development prospects and opportunities of Chronic Kidney Disease (CKD) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Kidney Disease (CKD) market in Chapter 13.

    By Player:

    • Sanofi

    • GlaxoSmithKline

    • FibroGen

    • Roche

    • Johnson & Johnson

    • Keryx

    • AbbVie

    • AstraZeneca

    • Pfizer

    • Kissei

    • Allergan

    • Amgen

    • Teva

    By Type:

    • Calcium channel blockers

    • Antihypertensive

    • Anemia Treatment Drugs

    • Others

    By End-User:

    • Hospital

    • Clinic

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chronic Kidney Disease (CKD) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chronic Kidney Disease (CKD) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chronic Kidney Disease (CKD) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chronic Kidney Disease (CKD) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chronic Kidney Disease (CKD) Market Analysis and Outlook to 2022

    • 7.1 Global Chronic Kidney Disease (CKD) Consumption (2017-2022)

    • 7.2 United States Chronic Kidney Disease (CKD) Consumption (2017-2022)

    • 7.3 Europe Chronic Kidney Disease (CKD) Consumption (2017-2022)

    • 7.4 China Chronic Kidney Disease (CKD) Consumption (2017-2022)

    • 7.5 Japan Chronic Kidney Disease (CKD) Consumption (2017-2022)

    • 7.6 India Chronic Kidney Disease (CKD) Consumption (2017-2022)

    • 7.7 South Korea Chronic Kidney Disease (CKD) Consumption (2017-2022)

    8 Region and Country-wise Chronic Kidney Disease (CKD) Market Analysis and Outlook to 2028

    • 8.1 Global Chronic Kidney Disease (CKD) Consumption Forecast (2022-2028)

    • 8.2 United States Chronic Kidney Disease (CKD) Consumption Forecast (2022-2028)

    • 8.3 Europe Chronic Kidney Disease (CKD) Consumption Forecast (2022-2028)

    • 8.4 China Chronic Kidney Disease (CKD) Consumption Forecast (2022-2028)

    • 8.5 Japan Chronic Kidney Disease (CKD) Consumption Forecast (2022-2028)

    • 8.6 India Chronic Kidney Disease (CKD) Consumption Forecast (2022-2028)

    • 8.7 South Korea Chronic Kidney Disease (CKD) Consumption Forecast (2022-2028)

    9 Global Chronic Kidney Disease (CKD) Market Outlook by Types and Applications to 2022

    • 9.1 Global Chronic Kidney Disease (CKD) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Calcium channel blockers Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antihypertensive Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Anemia Treatment Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chronic Kidney Disease (CKD) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

    10 Global Chronic Kidney Disease (CKD) Market Outlook by Types and Applications to 2028

    • 10.1 Global Chronic Kidney Disease (CKD) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Calcium channel blockers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Antihypertensive Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Anemia Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chronic Kidney Disease (CKD) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chronic Kidney Disease (CKD) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chronic Kidney Disease (CKD) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chronic Kidney Disease (CKD) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chronic Kidney Disease (CKD) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chronic Kidney Disease (CKD) Market Competitive Analysis

    • 14.1 Sanofi

      • 14.1.1 Sanofi Company Details

      • 14.1.2 Sanofi Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sanofi Chronic Kidney Disease (CKD) Product and Service

    • 14.2 GlaxoSmithKline

      • 14.2.1 GlaxoSmithKline Company Details

      • 14.2.2 GlaxoSmithKline Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Product and Service

    • 14.3 FibroGen

      • 14.3.1 FibroGen Company Details

      • 14.3.2 FibroGen Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 FibroGen Chronic Kidney Disease (CKD) Product and Service

    • 14.4 Roche

      • 14.4.1 Roche Company Details

      • 14.4.2 Roche Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Roche Chronic Kidney Disease (CKD) Product and Service

    • 14.5 Johnson & Johnson

      • 14.5.1 Johnson & Johnson Company Details

      • 14.5.2 Johnson & Johnson Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Johnson & Johnson Chronic Kidney Disease (CKD) Product and Service

    • 14.6 Keryx

      • 14.6.1 Keryx Company Details

      • 14.6.2 Keryx Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Keryx Chronic Kidney Disease (CKD) Product and Service

    • 14.7 AbbVie

      • 14.7.1 AbbVie Company Details

      • 14.7.2 AbbVie Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AbbVie Chronic Kidney Disease (CKD) Product and Service

    • 14.8 AstraZeneca

      • 14.8.1 AstraZeneca Company Details

      • 14.8.2 AstraZeneca Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AstraZeneca Chronic Kidney Disease (CKD) Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Chronic Kidney Disease (CKD) Product and Service

    • 14.10 Kissei

      • 14.10.1 Kissei Company Details

      • 14.10.2 Kissei Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Kissei Chronic Kidney Disease (CKD) Product and Service

    • 14.11 Allergan

      • 14.11.1 Allergan Company Details

      • 14.11.2 Allergan Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Allergan Chronic Kidney Disease (CKD) Product and Service

    • 14.12 Amgen

      • 14.12.1 Amgen Company Details

      • 14.12.2 Amgen Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Amgen Chronic Kidney Disease (CKD) Product and Service

    • 14.13 Teva

      • 14.13.1 Teva Company Details

      • 14.13.2 Teva Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Teva Chronic Kidney Disease (CKD) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chronic Kidney Disease (CKD)

    • Figure Chronic Kidney Disease (CKD) Picture

    • Table Global Chronic Kidney Disease (CKD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Kidney Disease (CKD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Kidney Disease (CKD) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chronic Kidney Disease (CKD) Consumption by Country (2017-2022)

    • Figure United States Chronic Kidney Disease (CKD) Consumption and Growth Rate (2017-2022)

    • Table Europe Chronic Kidney Disease (CKD) Consumption and Growth Rate (2017-2022)

    • Figure China Chronic Kidney Disease (CKD) Consumption and Growth Rate (2017-2022)

    • Figure Japan Chronic Kidney Disease (CKD) Consumption and Growth Rate (2017-2022)

    • Figure India Chronic Kidney Disease (CKD) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chronic Kidney Disease (CKD) Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Kidney Disease (CKD) Consumption Forecast by Country (2022-2028)

    • Figure United States Chronic Kidney Disease (CKD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chronic Kidney Disease (CKD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chronic Kidney Disease (CKD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chronic Kidney Disease (CKD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chronic Kidney Disease (CKD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chronic Kidney Disease (CKD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Calcium channel blockers Consumption and Growth Rate (2017-2022)

    • Figure Global Antihypertensive Consumption and Growth Rate (2017-2022)

    • Figure Global Anemia Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Calcium channel blockers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antihypertensive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anemia Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chronic Kidney Disease (CKD) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chronic Kidney Disease (CKD) Export by Region (Top 5 Countries) (2017-2028)

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Chronic Kidney Disease (CKD) Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Chronic Kidney Disease (CKD) Product and Service

    • Table FibroGen (Foundation Year, Company Profile and etc.)

    • Table FibroGen Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table FibroGen Chronic Kidney Disease (CKD) Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Chronic Kidney Disease (CKD) Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Chronic Kidney Disease (CKD) Product and Service

    • Table Keryx (Foundation Year, Company Profile and etc.)

    • Table Keryx Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Keryx Chronic Kidney Disease (CKD) Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Chronic Kidney Disease (CKD) Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Chronic Kidney Disease (CKD) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Chronic Kidney Disease (CKD) Product and Service

    • Table Kissei (Foundation Year, Company Profile and etc.)

    • Table Kissei Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kissei Chronic Kidney Disease (CKD) Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Chronic Kidney Disease (CKD) Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Chronic Kidney Disease (CKD) Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Chronic Kidney Disease (CKD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Chronic Kidney Disease (CKD) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US